Atlas Trials

Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer

Clinical trial NCT01442519 · COMPLETED

Trial details

NCT number
NCT01442519
Sponsor
University of Rome Tor Vergata
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Bladder Cancer
Start date
1994-01-01
Primary completion
2002-06-01
Enrollment
212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.